ASTRO Strongly Supports Dr Monica Bertagnolli to Lead the NIH

The American Society for Radiation Oncology (ASTRO) expressed its strong support for President Joseph R Biden Jr’s nomination of Monica Bertagnolli, MD, as director of the National Institutes of Health (NIH) with the following statement from Geraldine M Jacobson, MD, MBA, MPH, FASTRO, Chair of the ASTRO Board of Directors:

“ASTRO applauds the nomination of cancer expert Dr. Monica Bertagnolli to lead the National Institutes of Health. Dr. Bertagnolli is a strong advocate for research, innovation and equity, as her work at the helm of the National Cancer Institute demonstrates.

The radiation oncology community looks forward to working with Dr. Bertagnolli in her new role at the NIH on efforts to improve American health care, such as initiatives to increase clinical trial diversity and accelerate research toward cancer cures. Given that more than half of people diagnosed with cancer will receive radiation therapy, we are particularly eager to work with her to ensure that radiation oncologists contribute meaningfully to achieving President Biden’s goal of reducing cancer mortality by 50% over the next 25 years.

We believe that Dr. Bertagnolli is the ideal person to lead the NIH at this critical time, and we urge the Senate to confirm her nomination as soon as possible.”